» Articles » PMID: 26486474

De Novo Dominant Variants Affecting the Motor Domain of KIF1A Are a Cause of PEHO Syndrome

Overview
Journal Eur J Hum Genet
Specialty Genetics
Date 2015 Oct 22
PMID 26486474
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

PEHO syndrome (OMIM no. 260565) is characterized by myoclonic jerking and infantile spasms, profound psychomotor retardation with the absence of motor milestones and speech, absence or early loss of visual fixation with atrophy of optic discs by 2 years of age and progressive brain atrophy on neuroimaging. We describe the results of a genomic study of a girl with PEHO syndrome and review the literature on cases with a disease-causing variant in the same gene. Exome sequencing of the index and unaffected parents followed by Sanger confirmation identified nine candidate genes harboring nonsynonymous rare variants identified by trio whole-exome sequencing. The de novo variant, a missense variant (c.296C>T, p.(T99M)), affecting the motor domain of KIF1A was considered the pathogenic mutation. The literature review revealed 24 cases with disease-causing variants in the motor domain of KIF1A, of which three met all the criteria for PEHO syndrome and an additional patient with incomplete clinical data met four of the five criteria. If the criteria were modified to include cases with any convulsive disorder and less profound intellectual disability, a total of six patients met all five of the criteria, three patients met four of the criteria and six met three of the criteria. Our results indicate that the molecular basis for PEHO syndrome, in at least a subset of patients, is a dominant KIF1A variant affecting the motor domain of the protein. Variable expressivity is seen with recurrent variants causing the full phenotype of PEHO syndrome in some patients and in other patients, a partial or milder PEHO phenotype.

Citing Articles

Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease.

Miao G, Zhang W, Xu Y, Liu Y, Lai P, Guo J Mil Med Res. 2025; 12(1):11.

PMID: 40038775 PMC: 11877712. DOI: 10.1186/s40779-025-00594-3.


Cryo-EM unveils kinesin KIF1A's processivity mechanism and the impact of its pathogenic variant P305L.

Benoit M, Rao L, Asenjo A, Gennerich A, Sosa H Nat Commun. 2024; 15(1):5530.

PMID: 38956021 PMC: 11219953. DOI: 10.1038/s41467-024-48720-4.


A plant flavonol and genetic suppressors rescue a pathogenic mutation associated with kinesin in neurons.

Chai Y, Li D, Gong W, Ke J, Tian D, Chen Z Proc Natl Acad Sci U S A. 2024; 121(5):e2311936121.

PMID: 38271337 PMC: 10835061. DOI: 10.1073/pnas.2311936121.


Autosomal dominant neurodevelopmental disorders associated with gene variants in 6 pediatric patients.

Lin J, Li N, Yao R, Yu T, Wang X, Wang J Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52(6):693-700.

PMID: 38105687 PMC: 10764188. DOI: 10.3724/zdxbyxb-2023-0457.


Expanding the Knowledge of KIF1A-Dependent Disorders to a Group of Polish Patients.

Paprocka J, Jezela-Stanek A, Smigiel R, Walczak A, Mierzewska H, Kutkowska-Kazmierczak A Genes (Basel). 2023; 14(5).

PMID: 37239332 PMC: 10217861. DOI: 10.3390/genes14050972.


References
1.
Alfadhel M, Yong S, Lillquist Y, Langlois S . Precocious puberty in two girls with PEHO syndrome: a clinical feature not previously described. J Child Neurol. 2011; 26(7):851-7. DOI: 10.1177/0883073810396582. View

2.
Fujimoto S, Yokochi K, Nakano M, Wada Y . Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome) in two Japanese siblings. Neuropediatrics. 1995; 26(5):270-2. DOI: 10.1055/s-2007-979771. View

3.
Ylikallio E, Kim D, Isohanni P, Auranen M, Kim E, Lonnqvist T . Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia. Eur J Hum Genet. 2015; 23(10):1427-30. PMC: 4592090. DOI: 10.1038/ejhg.2014.297. View

4.
Okamoto N, Miya F, Tsunoda T, Yanagihara K, Kato M, Saitoh S . KIF1A mutation in a patient with progressive neurodegeneration. J Hum Genet. 2014; 59(11):639-41. DOI: 10.1038/jhg.2014.80. View

5.
Hamdan F, Gauthier J, Araki Y, Lin D, Yoshizawa Y, Higashi K . Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet. 2011; 88(3):306-16. PMC: 3059427. DOI: 10.1016/j.ajhg.2011.02.001. View